Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Jan;54(1):86-97. doi: 10.1111/trf.12250. Epub 2013 May 21.

2.

Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.

Transfusion. 2014 Aug;54(8):2034-44. doi: 10.1111/trf.12585. Epub 2014 Feb 27.

3.

Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Gehrie EA, Ness PM, Bloch EM, Kacker S, Tobian AAR.

Transfusion. 2017 Sep;57(9):2267-2276. doi: 10.1111/trf.14212. Epub 2017 Jun 26. Review.

4.

The future of red blood cell alloimmunization risk reduction.

Karafin MS, Denomme GA, Bryant BJ.

Transfusion. 2015 Jan;55(1):220-1. doi: 10.1111/trf.12863. No abstract available.

PMID:
25582238
5.

The future of red blood cell alloimmunization risk reduction.

Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AA.

Transfusion. 2015 Jan;55(1):222-4. doi: 10.1111/trf.12866. No abstract available.

6.

Prospective antigen matching strategies fail to fit the model.

Webb J, Chou ST.

Transfusion. 2015 Jan;55(1):221-2. doi: 10.1111/trf.12924. No abstract available.

PMID:
25582239
7.

Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

Transfusion. 2013 Apr;53(4):704-9. doi: 10.1111/j.1537-2995.2012.03796.x. Epub 2012 Jul 13.

8.

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).

Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR.

Transfusion. 2011 Aug;51(8):1732-9. doi: 10.1111/j.1537-2995.2010.03045.x. Epub 2011 Feb 18.

PMID:
21332724
9.

Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.

Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM.

Transfusion. 2017 Nov;57(11):2738-2746. doi: 10.1111/trf.14282. Epub 2017 Aug 24.

PMID:
28840600
10.
11.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.

Blood. 2013 Aug 8;122(6):1062-71. doi: 10.1182/blood-2013-03-490623. Epub 2013 May 30.

12.

Alloimmunization in sickle cell anemia in the era of extended red cell typing.

O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.

Pediatr Blood Cancer. 2013 Sep;60(9):1487-91. doi: 10.1002/pbc.24530. Epub 2013 Mar 18.

PMID:
23508932
13.

Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.

Venkateswaran L, Teruya J, Bustillos C, Mahoney D Jr, Mueller BU.

Pediatr Blood Cancer. 2011 Aug;57(2):294-6. doi: 10.1002/pbc.22985. Epub 2011 Feb 4.

PMID:
21298771
14.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
15.

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ; Stroke Prevention Trail in Sickle Cell Anemia.

Transfusion. 2001 Sep;41(9):1086-92.

PMID:
11552063
16.

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.

Ambruso DR, Githens JH, Alcorn R, Dixon DJ, Brown LJ, Vaughn WM, Hays T.

Transfusion. 1987 Jan-Feb;27(1):94-8.

PMID:
3810834
17.

Antigen-matched donor blood in the transfusion management of patients with sickle cell disease.

Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD.

Transfusion. 1994 Jul;34(7):562-9.

PMID:
8053036
18.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
19.

Relevance of blood groups in transfusion of sickle cell disease patients.

Noizat-Pirenne F.

C R Biol. 2013 Mar;336(3):152-8. doi: 10.1016/j.crvi.2012.09.011. Epub 2013 Feb 7. Review.

PMID:
23643398
20.

Transfusion therapy for sickle cell disease: a balancing act.

Chou ST.

Hematology Am Soc Hematol Educ Program. 2013;2013:439-46. doi: 10.1182/asheducation-2013.1.439. Review.

PMID:
24319217

Supplemental Content

Support Center